Author

Austin W. Goodrich

Observed names: Austin Goodrich, Austin W Goodrich

Institution: Mayo Clinic

Observed institution: Mayo Clinic

ORCID: 0009-0008-5596-0873

Observed ORCID: 0009-0008-5596-0873

OpenAlex ID: A5103179336

Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies

2024 · Neha Atulkumar Singh, Austin W. Goodrich, et al. · NeuroImage · 19

Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech

2024 · Danna P. Garcia-Guaqueta, Hugo Botha, et al. · Journal of Neurology · 9

Relationships between hypometabolism and both β‐amyloid and tau PET in corticobasal syndrome

2025 · Alma Ghirelli, Austin W. Goodrich, et al. · Alzheimer s & Dementia · 6

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

2023 · Aaron Scott Mansfield, Austin Goodrich, et al. · Journal of Clinical Oncology · 2

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

2022 · Aaron Scott Mansfield, Austin Goodrich, et al. · Journal of Clinical Oncology · 1

The Impact of Lung and Heart Radiation Dose During Preoperative Chemoradiation on Overall Survival in Esophageal Cancer—A Post Hoc Analysis of CALGB 80803 (Alliance)

2026 · Eric J. Lehrer, Susan Geyer, et al. · International Journal of Radiation Oncology*Biology*Physics

Progression of Nonfluent Primary Progressive Aphasia and Primary Progressive Apraxia of Speech into Corticobasal Syndrome (S43.001)

2024 · Danna Garcia-Guaqueta, Hugo Botha, et al. · Neurology

Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathology

2024 · Carling G. Robinson, Austin W. Goodrich, et al. · Journal of the International Neuropsychological Society

Within and between‐network functional connectivity disruptions in posterior cortical atrophy and dementia with Lewy bodies

2023 · Neha Atulkumar Singh, Austin W Goodrich, et al. · Alzheimer s & Dementia

Alliance A022102: Randomized phase III trial of mFOLFIRINOX +/- nivolumab vs. FOLFOX +/- nivolumab for first-line treatment of metastatic HER2-negative gastroesophageal adenocarcinoma (GEA).

2023 · Haeseong Park, Susan Michelle Geyer, et al. · Journal of Clinical Oncology

Works count: 10

Citation count: 37

H-index: 3

I10-index: 1